# Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities

> **NCT01431105** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 34 (actual)

## Conditions studied

- Kawasaki Disease

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT01431105
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2018-01
- **Final completion:** 2018-07
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2020-05-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01431105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01431105, "Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01431105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*